Abstract:Gibberellin A3 (GA3), a highly active plant growth regulator, is widely used in agricultural production. To develop a microbial cell factory for efficient GA3 synthesis, this study achieved the de novo biosynthesis of GA3 with Saccharomyces cerevisiae as the chassis strain. First, on the basis of the gibberellin biosynthesis pathway of Gibberella fujikuroi, key genes for GA3 synthesis were integrated, which, combined with the overexpression of mevalonate pathway genes (tHMG1 and IDI1), resulting in a GA3 titer of 595 μg/L. Next, to enhance the catalytic efficiency of P450 enzymes, we optimized intracellular NADPH and heme supply by overexpressing ZWF1, POS5Δ17, and HME3, increasing the GA3 titer to 1.73 mg/L. Subsequently, the integration of Arabidopsis thaliana-derived membrane-bound scaffold protein AtMSBP1 enabled the co-localization of P450 enzymes and CPR on the endoplasmic reticulum membrane, enhancing their spatial proximity and functional coupling, thereby improving the electron transfer efficiency and raising the GA3 titer to 4.32 mg/L. Finally, high-cell-density fed-batch fermentation in a 5 L bioreactor further increased the GA3 titer to 14.17 mg/L. These results demonstrate that the engineered strain exhibits promising scalability and metabolic stability, providing a feasible strategy for the microbial production of gibberellins.